{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:19:46Z","timestamp":1792120786400,"version":"4.4.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["2015132"],"award-info":[{"award-number":["2015132"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Doris Duke Charitable Foundation (US)","award":["2010036"],"award-info":[{"award-number":["2010036"]}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL-090941"],"award-info":[{"award-number":["R01-HL-090941"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL-078787"],"award-info":[{"award-number":["R01-HL-078787"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL-095647"],"award-info":[{"award-number":["R01-HL-095647"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0164364","type":"journal-article","created":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T17:43:09Z","timestamp":1475775789000},"page":"e0164364","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5427-9666","authenticated-orcid":true,"given":"Beverly A.","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofelia A.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Aygun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri A.","family":"Nottage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla W.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Piccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thad A.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell E.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,10,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1542\/peds.83.5.827","article-title":"Newborn experience in the Cooperative Study of Sickle Cell Disease","volume":"83","author":"FM Gill","year":"1989","journal-title":"Pediatrics"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"OS Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2007-07-100719","article-title":"Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort","volume":"111","author":"CT Quinn","year":"2008","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood.V86.2.776.bloodjournal862776","article-title":"Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease","volume":"86","author":"FM Gill","year":"1995","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM200001133420203","article-title":"Prediction of adverse outcomes in children with sickle cell disease","volume":"342","author":"ST Miller","year":"2000","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0895-4356(92)90073-V","article-title":"Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease","volume":"45","author":"MS West","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pbc.20645","article-title":"Early blood transfusions protect against microalbuminuria in children with sickle cell disease","volume":"47","author":"O Alvarez","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199202273260905","article-title":"The use of transcranial ultrasonography to predict stroke in sickle cell disease","volume":"326","author":"R Adams","year":"1992","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"MT Gladwin","year":"2004","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/pbc.21520","article-title":"Short-term follow-up of patients with sickle cell disease and albuminuria","volume":"50","author":"O Alvarez","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/00043426-200308000-00007","article-title":"Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia","volume":"25","author":"LL Hsu","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ajh.21264","article-title":"UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia","volume":"83","author":"SL Carpenter","year":"2008","journal-title":"Am J Hematol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ajh.23457","article-title":"Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes","volume":"88","author":"VA Sheehan","year":"2013","journal-title":"Am J Hematol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1182\/blood.V99.1.10","article-title":"Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy","volume":"99","author":"RE Ware","year":"2002","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2011-07-364190","article-title":"Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia","volume":"118","author":"RE Ware","year":"2011","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e1002108","DOI":"10.1371\/journal.pgen.1002108","article-title":"Genome-wide association study of white blood cell count in 16,388 African Americans: the continental origins and genetic epidemiology network (COGENT)","volume":"7","author":"AP Reiner","year":"2011","journal-title":"PLoS Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/hmg\/ddq080","article-title":"Common variations in PSMD3-CSF3 and PLCB4 are associated with neutrophil count","volume":"19","author":"Y Okada","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e1000360","DOI":"10.1371\/journal.pgen.1000360","article-title":"Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene","volume":"5","author":"D Reich","year":"2009","journal-title":"PLoS Genet"},{"key":"ref19","first-page":"809","article-title":"Microalbuminuria and progressive renal disease","volume":"8","author":"P Kilaru","year":"1994","journal-title":"J Hum Hypertens"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5414\/CN108138","article-title":"The association of endothelial nitric oxide synthase gene G894T polymorphism and serum nitric oxide concentration with microalbuminuria in patients with gestational diabetes","volume":"81","author":"AE Atay","year":"2014","journal-title":"Clin Nephrol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ndt\/gft386","article-title":"The association of a single-nucleotide polymorphism in CUBN and the risk of albuminuria and cardiovascular disease","volume":"29","author":"GM McMahon","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1056\/NEJMe1312797","article-title":"Health disparities in kidney disease\u2014emerging data from the human genome","volume":"369","author":"WW Williams","year":"2013","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)","volume":"119","author":"RE Ware","year":"2012","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"RE Ware","year":"2016","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1182\/blood-2009-04-146852","article-title":"How I use hydroxyurea to treat young patients with sickle cell anemia","volume":"115","author":"RE Ware","year":"2010","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/pbc.24100","article-title":"Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia","volume":"59","author":"O Alvarez","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpeds.2009.06.060","article-title":"Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial","volume":"156","author":"RE Ware","year":"2010","journal-title":"J Pediatr"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"GJ Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00439-011-1103-9","article-title":"Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network","volume":"131","author":"DR Crosslin","year":"2012","journal-title":"Hum Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e88273","DOI":"10.1371\/journal.pone.0088273","article-title":"Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease","volume":"9","author":"ND Palmer","year":"2014","journal-title":"PloS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","article-title":"APOL1 kidney risk alleles: population genetics and disease associations","volume":"21","author":"S Limou","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1182\/blood-2012-10-464156","article-title":"Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia","volume":"121","author":"JM Flanagan","year":"2013","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e110740","DOI":"10.1371\/journal.pone.0110740","article-title":"Whole exome sequencing identifies novel genes for fetal hemoglobin response to hydroxyurea in children with sickle cell anemia","volume":"9","author":"VA Sheehan","year":"2014","journal-title":"PloS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1537-2995.2007.01622.x","article-title":"Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease","volume":"48","author":"A Afenyi-Annan","year":"2008","journal-title":"Transfusion (Paris)"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","article-title":"MYH9 and APOL1 are both associated with sickle cell disease nephropathy","volume":"155","author":"AE Ashley-Koch","year":"2011","journal-title":"Br J Haematol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/asheducation-2015.1.436","article-title":"Optimizing hydroxyurea therapy for sickle cell anemia","volume":"2015","author":"RE Ware","year":"2015","journal-title":"Hematol Educ Program Am Soc Hematol Am Soc Hematol Educ Program"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2013.12.032","article-title":"ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state","volume":"6","author":"Y Chudnovsky","year":"2014","journal-title":"Cell Rep"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1248\/bpb.29.1830","article-title":"A homeodomain-zinc finger protein, ZFHX4, is expressed in neuronal differentiation manner and suppressed in muscle differentiation manner","volume":"29","author":"K Hemmi","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1038\/ncomms7825","article-title":"New basal cell carcinoma susceptibility loci","volume":"6","author":"SN Stacey","year":"2015","journal-title":"Nat Commun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.amjmed.2008.11.021","article-title":"White\/black racial differences in risk of end-stage renal disease and death","volume":"122","author":"AI Choi","year":"2009","journal-title":"Am J Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1681\/ASN.2010070730","article-title":"The Apolipoprotein L1 (APOL1) Gene and Nondiabetic Nephropathy in African Americans","volume":"21","author":"BI Freedman","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"F326","DOI":"10.1152\/ajprenal.00647.2013","article-title":"APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability","volume":"307","author":"X Lan","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3324\/haematol.2015.124875","article-title":"Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy","volume":"100","author":"SL Saraf","year":"2015","journal-title":"Haematologica"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00467-011-1857-2","article-title":"Glomerular hyperfiltration and albuminuria in children with sickle cell anemia","volume":"26","author":"B Aygun","year":"2011","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2215\/CJN.01600211","article-title":"Chronic kidney disease and albuminuria in children with sickle cell disease","volume":"6","author":"Yee M McPherson","year":"2011","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.cellsig.2013.04.007","article-title":"AGGF1 is a novel anti-inflammatory factor associated with TNF-\u03b1-induced endothelial activation","volume":"25","author":"F-Y Hu","year":"2013","journal-title":"Cell Signal"},{"key":"ref47","article-title":"Angiogenic factor with G patch and FHA domains 1 (Aggf1) regulates liver fibrosis by modulating TGF-\u03b2 signaling","author":"B Zhou","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"ref48","article-title":"A novel long non-coding RNA CYP4B1-PS1-001 regulates proliferation and fibrosis in diabetic nephropathy","author":"M Wang","journal-title":"Mol Cell Endocrinol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/CIRCULATIONAHA.107.712539","article-title":"Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis","volume":"117","author":"T Watanabe","year":"2008","journal-title":"Circulation"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.atherosclerosis.2010.04.027","article-title":"Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice","volume":"212","author":"M Nagashima","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"H96","DOI":"10.1152\/ajpheart.00009.2012","article-title":"Salusin-\u03b2 accelerates inflammatory responses in vascular endothelial cells via NF-\u03baB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro","volume":"303","author":"T Koya","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygeno.2004.02.008","article-title":"Polycystin-1L2 is a novel G-protein-binding protein","volume":"84","author":"T Yuasa","year":"2004","journal-title":"Genomics"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1182\/blood-2005-03-1014","article-title":"CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin","volume":"107","author":"DJ Schaer","year":"2006","journal-title":"Blood"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.RES.0000247067.34173.1b","article-title":"Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin","volume":"99","author":"CA Schaer","year":"2006","journal-title":"Circ Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/bjh.13326","article-title":"Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy","volume":"169","author":"RS Nickel","year":"2015","journal-title":"Br J Haematol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1182\/blood-2012-10-464156","article-title":"Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia","volume":"121","author":"JM Flanagan","year":"2013","journal-title":"Blood"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0164364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T21:21:24Z","timestamp":1657401684000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0164364"}},"subtitle":[],"editor":[{"given":"Philippe","family":"Connes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,6]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0164364","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,6]]}}}